The Breast Cancer Research Foundation

The Breast Cancer Research Foundation We are the highest-rated breast cancer organization in the U.S. We fund research to find a cure for breast cancer in our lifetime.

The Breast Cancer Research Foundation (BCRF) is the largest private funder of breast cancer research—and metastatic breast cancer research—worldwide and is the highest-rated breast cancer research organization in the U.S.

05/10/2026

After her breast cancer diagnosis, Samantha became a mother of two—and her perspective shifted toward creating a healthier future for her children and families everywhere.

Through her work with The Pink Agenda, a longtime partner of Breast Cancer Research Foundation, she’s helping move research forward that brings more options and hope to future generations.

Today only, in honor of Mother's Day, your gift to BCRF will be 2X matched for double the impact to help fund lifesaving research. Act now at BCRF.org/donate.

Last week, BCRF was honored to partner with Churchill Downs as its National Philanthropy Partner for Kentucky Oaks and K...
05/08/2026

Last week, BCRF was honored to partner with Churchill Downs as its National Philanthropy Partner for Kentucky Oaks and Kentucky Derby weekend.

On Oaks Day, BCRF proudly participated in the iconic Survivors Parade, led by Bridget Bahl, honoring the resilience of those impacted by breast and ovarian cancer. Throughout the venue, guests had the opportunity to support lifesaving research through register round-up donations—bringing philanthropy directly into one of racing’s most celebrated traditions.

Together, we’re raising critical funds, honoring thrivers, and accelerating progress toward a world without breast cancer.

Last week, BCRF held its 20th annual Boston Hot Pink Party and raised more than $2.1 million for lifesaving research! Th...
05/07/2026

Last week, BCRF held its 20th annual Boston Hot Pink Party and raised more than $2.1 million for lifesaving research! The milestone evening honored BCRF Honorary Chair, in memoriam, Leonard A. Lauder, celebrating his extraordinary legacy and lasting impact on breast cancer research.

BCRF Board Co-chair Karen Hale opened the program with welcome remarks, followed by a special tribute from Robert Kraft honoring Leonard A. Lauder and recognizing his unwavering commitment to accelerating breast cancer research.

BCRF Scientific Director Judy Garber shared the latest breakthroughs in the field, while Abby and Al Pastyrnak delivered moving remarks on the power of research in Abby’s experience living with metastatic breast cancer. Guests were then treated to a special performance by DJ Jazzy Jeff.

This year, BCRF is awarding more than $8.9 million in grants to 42 scientists across New England, bringing its total investment in the region to over $144 million.

Special thanks to the Boston community and everyone involved for making this milestone event such a success. 💗

📸: Thanks to Michael Blanchard

Invasive lobular carcinoma, also referred to as invasive lobular breast cancer, is the second most common type of breast...
05/06/2026

Invasive lobular carcinoma, also referred to as invasive lobular breast cancer, is the second most common type of breast cancer after invasive ductal carcinoma. Lobular carcinoma is treatable but has a unique biology that affects symptoms, diagnosis, and therapeutic strategies.

Learn more about lobular breast cancer and what BCRF is doing to accelerate lifesaving research at the link in comments.

This Asian American and Pacific Islander (AAPI) Heritage Month, we’re highlighting an urgent and often overlooked trend ...
05/04/2026

This Asian American and Pacific Islander (AAPI) Heritage Month, we’re highlighting an urgent and often overlooked trend in breast cancer.

Breast cancer rates in AAPI women have increased nearly 50% since 2000, and AAPI women now represent the largest group of women diagnosed under 40.

These shifts underscore the importance of continued research, early detection, and equitable access to care for all communities.

BCRF is committed to funding research that helps us better understand these disparities—and work toward better outcomes for everyone.

Learn more about how BCRF is advancing research on AAPI breast cancer risk and outcomes at the link in comments.

New information—and misinformation—about breast cancer seems to surface every day.Join us for a live discussion on May 1...
04/30/2026

New information—and misinformation—about breast cancer seems to surface every day.

Join us for a live discussion on May 14th at 1pm ET exploring some of the biggest myths, facts, and questions in breast cancer today.

Hear from BCRF researchers Veronica Jones, MD and Evanthia Roussos Torres, MD, PhD, moderated by Sadia Haque Zapp, as they break down what you really need to know about topics like AI-guided screening, hormone therapy and menopause, DCIS, GLP-1s, and more.

Sign up for free here: https://bit.ly/4tCpR2x

04/28/2026

Patient advocacy saves lives.

As we close out National Minority Health Month, BCRF investigator Dr. Sonya Reid highlights how thrivers, survivors, and community partners help underrepresented patients get screened earlier, stay on track with treatment, and navigate care.

Learn about breast cancer disparities and what BCRF investigators are doing to close gaps in outcomes: https://bit.ly/4qn3uNg

04/23/2026

We met with BCRF investigator Dr. Virginia Borges to break down what the science actually shows about common misconceptions surrounding breast cancer in younger women—and what current evidence does (and doesn’t) support.

BCRF-funded research helps turn questions and confusion into clarity, empowering patients to make informed decisions about their health.

Breast cancer treatment can raise important questions about fertility.While the disease itself doesn’t affect fertility,...
04/22/2026

Breast cancer treatment can raise important questions about fertility.

While the disease itself doesn’t affect fertility, treatments like chemotherapy and hormone therapy can impact reproductive health—making early conversations about options essential.

The encouraging news: fertility preservation is possible, and research continues to expand what’s safe and achievable for patients and survivors.

This National Infertility Awareness Week, we’re highlighting what every patient deserves to know: fertility should be part of the care conversation from the start.

Learn more at the link in comments.

04/21/2026

We're shining a light on Infertility Awareness Week because we know younger patients are most concerned about fertility after cancer—a concern second only to surviving. But thanks to research, more and more, cancer doesn't always have the last word when it comes to having a child. Anna shares how research shaped, and continues to shape, fertility decisions after breast cancer.

From fertility preservation to timing pregnancy after treatment, ongoing science is helping patients make more informed choices about their futures. This includes findings from the BCRF-supported POSITIVE trial, which has helped guide safer timing for temporarily pausing endocrine therapy to allow pregnancy in patients with ER+ breast cancer.

BCRF is proud to support research that advances this understanding and improves care for young patients navigating survivorship.

04/16/2026

At just 27, Rana was diagnosed with breast cancer in the middle of medical school.

Today, she’s cancer-free—and a proud mom to her daughter, Ruby—thanks in part to BCRF-funded research that made it possible for her to safely pursue IVF.

This Giving Day, help make more stories like Rana’s possible. Right now, your gift is 3X matched for TRIPLE the impact. Act now at BCRF.org/donate.

Address

New York, NY

Alerts

Be the first to know and let us send you an email when The Breast Cancer Research Foundation posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organization

Send a message to The Breast Cancer Research Foundation:

Share